Pharma news
Americas
Janssen, a subsidiary of Johnson & Johnson, has acquired an anti-depressant drug candidate in a $25 million deal with Cerecor. 17 August 2017
Americas
The Biotechnology Industry Organization and the Pharmaceutical Research and Manufacturers of America, two trade groups representing US pharmaceutical companies, have backed Acorda in an appeal to the US Court of Appeals for the Federal Circuit. 17 August 2017
Americas
US President Donald Trump has put an end to his manufacturing council after a series of resignations. 17 August 2017
Americas
Par Pharmaceutical has sued a pair of former employees who set up a rival company, accusing them of poaching staff to steal trade secrets. 17 August 2017
Americas
Kenneth Frazier, the CEO of Merck, is one of three chief executives to step down from US President Donald Trump’s manufacturing council. 15 August 2017
Americas
A US judge has ruled that five patents owned by Pfizer are not invalid as obvious, in a dispute over a generic produced by Mylan. 14 August 2017
Americas
Jazz Pharmaceuticals has taken issue with a trademark application filed by Novartis in the US, filing an opposition at the Trademark Trial and Appeal Board. 14 August 2017
Americas
Big pharma is confronted with little competition in Mexico, with 22 drugs facing no generic rivals in the country. 10 August 2017
Americas
The US Food and Drug Administration finalised 46 product-specific bioequivalence guidances in August. 9 August 2017
Americas
Biopharmaceutical company Dermira has acquired the licensing rights to lebrikizumab, a treatment for atopic dermatitis, from Roche. 9 August 2017